ライフサイエンスコーパス: Gram-negative

1 included in the study (196 Gram-positive, 44 Gram-negative, 32 polymicrobial, and 29 non-VG targets),

2 Antibiotics with a broad spectrum of gram-negative activity accounted for 30.4% (95% CI, 29.0

3 Antibiotics with a broad spectrum of gram-negative activity accounted for a large portion of

4 Ellisiiamide A demonstrated Gram-negative activity against Escherichia coli BW25113,

5 he third ring was particularly important for Gram-negative activity.

6 The Gram-negative anaerobe, Porphyromonas gingivalis, is a k

7 the detection of the presence or absence of Gram-negative and -positive bacteria in the samples.

8 ch we call 'necrosignaling', exists in other Gram-negative and Gram-positive bacteria and displays sp

9 hylenediaminetetraacetic acid) inhibited all Gram-negative and Gram-positive bacteria tested.

10 ics), a high-throughput scRNA-seq method for Gram-negative and Gram-positive bacteria that can resolv

11 ficant photoinactivation (up to 95%) against Gram-negative and Gram-positive bacteria was observed wh

12 I-seq captures single-cell transcriptomes of Gram-negative and Gram-positive bacteria with high purit

13 of positive blood cultures in patients with Gram-negative and Gram-positive bacteria, including 8/60

14 ed the presence of RgNanOx homologues across Gram-negative and Gram-positive bacterial species and co

15 l and cytokine inflammatory response between Gram-negative and Gram-positive BK and to determine the

16 demonstrate label-free readout on unlabeled Gram-negative and Gram-positive species.

17 bactericidal activity extends to a range of Gram-negative and Gram-positive wound pathogens in plank

18 positive culture of more virulent bacteria (gram-negative and other gram-positive groups) and presen

19 (DD) to broth microdilution (BMD) for AST of Gram-negative bacilli (GNB).

20 Patients with multidrug-resistant gram-negative bacilli (MDR-GNB), accounting for 221 (14%

21 d bloodstream infection due to nonfermenting Gram-negative bacilli (odds ratio, 6.33; 95% CI, 1.59-25

22 a caused by gram-positive cocci, susceptible gram-negative bacilli (sGNB), resistant GNB (rGNB), and

23 lar catheter infections due to nonfermenting Gram-negative bacilli was high for the femoral insertion

24 related bloodstream infection, nonfermenting Gram-negative bacilli were more frequently detected at t

25 ized arterial catheters due to nonfermenting Gram-negative bacilli were more frequently observed at t

26 ved among pneumonias caused by nonfermenting gram-negative bacilli, but not Enterobacteriaceae or oth

27 The MICs of CFDC were determined for 610 Gram-negative bacilli, including 302 multinational Enter

28 eptibility testing using a collection of 297 Gram-negative bacilli, including members of the order En

29 fiderocol susceptibility results for certain Gram-negative bacilli.

30 array of multidrug-resistant (MDR), aerobic Gram-negative bacilli.

31 ted using a cohort of contemporary, clinical Gram-negative bacillus isolates from 3 U.S. academic med

32 ens is a red pigment (prodigiosin)-producing Gram-negative bacillus that is naturally found in soil a

33 h Staphylococcus aureus bacteremia (SAB) and gram-negative bacteremia (GNB) to compare the characteri

34 cal trial including adults hospitalized with gram-negative bacteremia conducted in 3 Swiss tertiary c

35 Gram-negative bacteremia is a common infection that resu

36 acterial assays with wild-type and resistant Gram negative bacteria carrying either single or multipl

37 Carbapenem-resistant Gram-negative bacteria (GNB) are heading the list of pat

38 IEps by Gram-negative bacteria (n = 210) outnumbered those by Gr

39 enterococci (P = .008), multidrug-resistant gram-negative bacteria (P = .016), or quinolone-resistan

40 bacteria (P = .016), or quinolone-resistant gram-negative bacteria (QR-GNB) (P = .015).

41 zed filters quickly killed Gram-positive and Gram-negative bacteria aerosols in vitro, with CFU reduc

42 Based on mouse studies, roles of gram-negative bacteria and altered intestinal homeostasi

43 ificities, moderately high sensitivities for Gram-negative bacteria and Candida species, and elevated

44 (P < 0.0001)-with pronounced differences for Gram-negative bacteria and Candida species.

45 s toward understanding betaOMP biogenesis in Gram-negative bacteria and in mitochondria.

46 S) are essential envelope components in many Gram-negative bacteria and provide intrinsic resistance

47 Gram-negative bacteria and their complex cell envelope,

48 eptation is critical to faithful division in Gram-negative bacteria and vital to the barrier function

49 Mitochondria, chloroplasts and Gram-negative bacteria are encased in a double layer of

50 Gram-negative bacteria are surrounded by an outer membra

51 rimeric porins in the outer membrane (OM) of Gram-negative bacteria are the conduits by which nutrien

52 A key group of quorum sensing molecules in Gram-negative bacteria are the N-acylhomoserine lactones

53 investigated the binding of CTRP6 to various Gram-negative bacteria as well as PRMs and enzymes of th

54 that neutrophils recognize Gram-positive and Gram-negative bacteria by means of multiple phagosomal T

55 S to recycle fatty acids may help pathogenic gram-negative bacteria circumvent FAS inhibition.

56 The outer membrane (OM) of gram-negative bacteria confers innate resistance to toxi

57 The Gram-negative bacteria E. coli and P. aeruginosa were pa

58 The asymmetric outer membrane (OM) of Gram-negative bacteria functions as a selective permeabi

59 The highly asymmetric outer membrane of Gram-negative bacteria functions in the defense against

60 However, some gram-negative bacteria harbor an enzyme known as the acy

61 Gram-negative bacteria have a cell envelope that compris

62 The LPS of Gram-negative bacteria have been shown to activate a nov

63 Pathogenic Gram-negative bacteria have developed several strategies

64 Not surprisingly, Gram-negative bacteria have evolved diverse posttranslat

65 Gram-negative bacteria have evolved numerous pathways to

66 Outer membrane vesicles (OMVs) produced by Gram-negative bacteria have roles in cell-to-cell signal

67 ogically efficacious therapy for fermenting, gram-negative bacteria in blood culture(s) if they were

68 m-resistant and/or multidrug-resistant (MDR) Gram-negative bacteria in clinical settings.

69 ntibacterial role against this bacterium and gram-negative bacteria in general.

70 ority pathogens listed by the WHO, including Gram-negative bacteria in the critical priority category

71 avelength) against multidrug-resistant (MDR) Gram-negative bacteria in vitro and in vivo.

72 g proteins (GBPs) assemble on the surface of Gram-negative bacteria into polyvalent signaling platfor

73 Cell-surface signaling (CSS) in Gram-negative bacteria involves highly conserved regulat

74 The cell envelope of Gram-negative bacteria is a multilayered structure essen

75 Lipopolysaccharide derived from Gram-negative bacteria is a potent activator of circulat

76 Carbapenem resistance in Gram-negative bacteria is a public health concern.

77 The outer membrane (OM) of Gram-negative bacteria is a selective permeability barri

78 The outer membrane (OM) of Gram-negative bacteria is an asymmetric lipid bilayer th

79 The outer-membrane of Gram-negative bacteria is critical for surface adhesion,

80 The outer membrane of Gram-negative bacteria is essential for their survival i

81 A major resistance mechanism in Gram-negative bacteria is the production of beta-lactama

82 l envelope stability(4); however, most other Gram-negative bacteria lack Lpp so it has been assumed t

83 CLs did not suspect that slow-growing, small Gram-negative bacteria might be harmful.

84 biotic enhancer properties against resistant Gram-negative bacteria of four antibiotics belonging to

85 his breaks the dogma that beta-lactams enter Gram-negative bacteria only by passive diffusion through

86 Gram stain for delineating gram-positive or gram-negative bacteria or fungi within corneal scrapes.

87 Gram-negative bacteria release outer membrane vesicles i

88 y; however, there is little knowledge on how Gram-negative bacteria release their OMs into their envi

89 Gram-negative bacteria repopulated in the smokers faster

90 hronic inflammatory disease characterized by Gram-negative bacteria responsible for the degradation o

91 Recent recurrent outbreaks of Gram-negative bacteria show the critical need to target

92 ow-derived macrophages (BMDMs) infected with Gram-negative bacteria such as Citrobacter rodentium, Es

93 outer membrane (OM) is a defining feature of Gram-negative bacteria that serves as a permeability bar

94 eview will focus on representative SLPs that gram-negative bacteria use to overcome host innate immun

95 nal domination (relative abundance >=30%) by gram-negative bacteria was used as predictor of gram-neg

96 The proportion of Gram-positive and Gram-negative bacteria were 135(68.2%) and 63(31.8%) res

97 aride (LPS) resides in the outer membrane of Gram-negative bacteria where it is responsible for barri

98 re important cell surface polysaccharides in gram-negative bacteria where they extend core lipopolysa

99 is an uncharacterized protein ubiquitous in Gram-negative bacteria whose gene frequently occurs in c

100 ns is the decoration of the outer surface of gram-negative bacteria with proteins tethered to the out

101 lity of most drug leads to accumulate inside Gram-negative bacteria(1-7).

102 gram-positive bacteria), TLR4 (receptor for gram-negative bacteria), or distilled water (control) an

103 not included): Gram-positive bacteria, 58%; Gram-negative bacteria, 78%; and Candida species, 83%.

104 the beta-barrel assembly machinery (BAM) in Gram-negative bacteria, and by the sorting and assembly

105 OMP folding is an essential process in all Gram-negative bacteria, and considering the looming cris

106 In Gram-negative bacteria, biodegradation depends on facili

107 positive bacteria and increased abundance of gram-negative bacteria, compared with mice given only wa

108 (LPS), a component of the outer membrane of gram-negative bacteria, disrupts the alveolar-capillary

109 Among Gram-negative bacteria, Escherichia coli were predominan

110 with efficacy against both gram-positive and gram-negative bacteria, has the potential to enhance tre

111 prevalent cause of antibiotic resistance in Gram-negative bacteria, i.e., the deactivation of the mo

112 S in vitro and inhibit the growth of diverse Gram-negative bacteria, including polymyxin-resistant st

113 tibacterial agents with activity against MDR Gram-negative bacteria, including WHO priority pathogens

114 (LPS), an inflammatory stimulus derived from gram-negative bacteria, is present in the normal GI trac

115 the major component of the outer membrane of gram-negative bacteria, lipopolysaccharide (LPS), binds

116 In the outer membrane of Gram-negative bacteria, membrane proteins are thought to

117 Gram-negative bacteria, mitochondria, and chloroplasts a

118 ay of isoprenoid synthesis, is essential for Gram-negative bacteria, mycobacteria and apicomplexans(2

119 mediated by lipid A aminoarabinosylation in Gram-negative bacteria, namely, ArnT (undecaprenyl phosp

120 In the outer membrane of gram-negative bacteria, O-antigen segments of lipopolysa

121 In Gram-negative bacteria, PG is assembled in the cytoplasm

122 tive staphylococci, other gram-positive, and gram-negative bacteria, respectively.

123 On Gram-negative bacteria, S-layers are anchored to cells v

124 In Gram-negative bacteria, the beta-barrel assembly machine

125 In Gram-negative bacteria, the folding and insertion of bet

126 nhances combinatorial antigenic diversity in Gram-negative bacteria, while reducing associated fitnes

127 ctivity against the tested Gram-positive and Gram-negative bacteria, with a large zone of inhibition

128 uring LPS transfection; however, its role in Gram-negative bacteria-mediated NLRP3 inflammasome activ

129 st the rising threat of multi-drug-resistant Gram-negative bacteria.

130 stigation of novel substances active against Gram-negative bacteria.

131 ltiprotein system present in the envelope of Gram-negative bacteria.

132 occus aureus, representing Gram-positive and Gram-negative bacteria.

133 fied antimicrobial resistance (AMR) genes in Gram-negative bacteria.

134 re key antibiotic resistance determinants in Gram-negative bacteria.

135 nflammasome activation during infection with Gram-negative bacteria.

136 SS) is a pivotal virulence mechanism of many Gram-negative bacteria.

137 mes that are secreted by almost all forms of Gram-negative bacteria.

138 ell wall component of both Gram-positive and Gram-negative bacteria.

139 ars ago and have been extensively studied in Gram-negative bacteria.

140 kines were quantified in keratitis caused by Gram-negative bacteria.

141 positive bacteria and lipopolysaccharides of Gram-negative bacteria.

142 cell wall is widely conserved across diverse Gram-negative bacteria.

143 c leukemia (ALL) to decrease infections with gram-negative bacteria.

144 an early predictive marker of BCV rupture by Gram-negative bacteria.

145 cellular compartment that is the hallmark of Gram-negative bacteria.

146 cant differences among the Gram-positive and Gram-negative bacteria.

147 nfections specifically caused by XDR and PDR Gram-negative bacteria.

148 h3-PA0808 pair are widely distributed across Gram-negative bacteria.

149 ATR system appears to be conserved in other Gram-negative bacteria.

150 enzyme that is conserved in the majority of gram-negative bacteria.

151 medical need created by multidrug resistant Gram-negative bacteria.

152 ever, smokers exhibit faster repopulation of Gram-negative bacteria.

153 fically how the inflammasome is activated by Gram-negative bacteria.

154 responds to osmolarity and acidic pH in many Gram-negative bacteria.

155 division (RND) superfamily are ubiquitous in Gram-negative bacteria.

156 r membrane is a key virulence determinant of gram-negative bacteria.

157 man infections caused by multidrug-resistant Gram-negative bacteria.

158 of FMN riboswitch binders against wild-type Gram-negative bacteria.

159 ral Vibrio species and a set of monotrichous Gram-negative bacteria.

160 d enzymes that confer colistin resistance in Gram-negative bacteria.

161 e scored as bacteria/fungi/none (BAC One) or gram-negative bacteria/none (BAC Two) and compared to Gr

162 trum of activity against multidrug-resistant Gram-negative bacteria; however, breakpoints have been e

163 ion and penetration of the Gram-positive and Gram-negative bacterial cell envelope, but do not ruptur

164 pleiotropic effects on the functionality of gram-negative bacterial cell envelopes.

165 is of intact proteins from Gram-positive and Gram-negative bacterial colonies sampled directly on sol

166 antimicrobial resistance phenotypes, during Gram-negative bacterial infection and will advance our u

167 N-hexanoyl-L-homoserine lactone (199 Da), a gram-negative bacterial infection biomarker.

168 provides critical hints for host response to Gram-negative bacterial infections and development of di

169 Gram-negative bacterial infections are a significant pub

170 Multidrug resistant Gram-negative bacterial infections are an increasing pub

171 tment of a wide range of multidrug resistant Gram-negative bacterial infections, by both intravenous

172 y/mortality rates with carbapenem-resistant, Gram-negative bacterial infections.

173 Gram-negative bacterial lipoproteins are triacylated wit

174 harges influence their interactions with the Gram-negative bacterial membranes.

175 Klebsiella pneumoniae is a Gram-negative bacterial pathogen that causes a range of

176 rtunistic and frequently multidrug-resistant Gram-negative bacterial pathogen that primarily infects

177 CTX-M beta-lactamases are widespread in Gram-negative bacterial pathogens and provide resistance

178 Many Gram-negative bacterial pathogens antagonize anti-bacter

179 ross prokaryotes, and in particular, several Gram-negative bacterial pathogens including Neisseria me

180 Many Gram-negative bacterial pathogens interact with mammalia

181 Treatment of multidrug-resistant Gram-negative bacterial pathogens represents a critical

182 Many Gram-negative bacterial pathogens use type III secretion

183 crobial activities against gram-positive and gram-negative bacterial pathogens, the avian protozoan E

184 ng virulence and conjugation operons in many Gram-negative bacterial pathogens.

185 ated the effect of maternal quinolone use on gram-negative bacterial resistance to quinolones in thei

186 richia coli epitomizes these obstacles: this gram-negative bacterial species is the most prevalent ag

187 erophore cephalosporin with activity against Gram-negative bacterial species that are resistant to ca

188 anscription of foreign genes in a variety of Gram-negative bacterial species.

189 oped a method to directly detect and map the Gram-negative bacterial virulence factor lipid A derived

190 d aggregate lipopolysaccharide (LPS) and the Gram-negative bacterium Escherichia coli However, the ph

191 isine A showed moderate activity against the Gram-negative bacterium Escherichia coli, but no further

192 In the Gram-negative bacterium Escherichia coli, membrane-bound

193 Stenotrophomonas maltophilia is a Gram-negative bacterium found ubiquitously in the enviro

194 inosa IMPORTANCE Pseudomonas aeruginosa is a Gram-negative bacterium frequently isolated from infecte

195 Infection with the Gram-negative bacterium Helicobacter pylori remains the

196 Chemical-induced spores of the Gram-negative bacterium Myxococcus xanthus are peptidogl

197 five bacterial diguanylate cyclases from the Gram-negative bacterium Salmonella Enteritidis, identify

198 Here, we show that the cytosolic Gram-negative bacterium Shigella flexneri stalls apoptos

199 Pseudomonas aeruginosa, a Gram-negative bacterium that commonly colonizes the airw

200 ica serovar Typhimurium (S Typhimurium) is a Gram-negative bacterium that induces cell death of macro

201 Helicobacter pylori is a gram-negative bacterium that persistently colonizes the

202 Klebsiella pneumoniae, a Gram-negative bacterium, is notorious for causing HAI, w

203 tibiofilm activity against gram-positive and gram-negative biofilms.

204 m-negative bacteria was used as predictor of gram-negative bloodstream infection using Cox proportion

205 etes were associated with protection against gram-negative bloodstream infection.

206 e question "Does transitioning patients with gram-negative bloodstream infections from intravenous to

207 Gram-negative bloodstream infections represent a signifi

208 ntestinal microbiota is connected to risk of gram-negative bloodstream infections, expanding on our p

209 how RDTs influence antibiotic management for Gram-negative BSIs and whether RDT results are acted on

210 to unnecessary escalation of antibiotics for Gram-negative BSIs.

211 t only in Gram-positive bacteria but also in Gram-negative C. jejuni, advancing our knowledge of the

212 y known requirements for PIC targeting are a Gram-negative cell envelope and a unique cell surface an

213 We use our findings to propose a model of Gram-negative cell envelope stabilization that includes

214 Here we highlight defenses utilized by Gram-negative cells against type VI secretion system (T6

215 high level in E. coli, is effective against Gram-negative clinical isolates, and has efficacy in mou

216 e treated empirically without broad-spectrum Gram-negative coverage, with clinical cure in 69.7%.

217 For Gram-negative cultures, the Verigene result correlated w

218 lethanolamine/phosphatidylglycerol mimics of Gram-negative cytoplasmic membranes.

219 he rod-shaped cells of Myxococcus xanthus, a Gram-negative deltaproteobacterium, differentiate to env

220 causing the initial bacteremia), restarting gram-negative-directed antibiotic therapy due to clinica

221 harge values of -80 to -140 mC m(-2) for the Gram-negative E. coli.

222 o inhibit both gram-positive (S. aureus) and gram-negative (E. coli) bacteria on solid and porous sur

223 This study investigated the inactivation of Gram-negative Escherichia coli (E. coli) and Gram-positi

224 vironment of two live bacterial strains: the Gram-negative Escherichia coli and the Gram-positive Bac

225 lied for Gram-positive Bacillus subtilis and Gram-negative Escherichia coli as model organisms to mon

226 a bacterial lysate consisting of heat-killed Gram-negative Escherichia coli Symbio and Gram-positive

227 ed Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacterial pathogens as

228 or Gram-positive (Enterococcus faecalis) and Gram-negative (Escherichia coli) reference strains and w

229 gainst Gram-positive (Bacillus subtilis) and Gram-negative (Escherichia coli) targets.

230 ctivity against a panel of gram-positive and gram-negative ESKAPE pathogens, and antibiofilm activity

231 Vibrio cholerae is a Gram-negative, facultative anaerobic bacterial species t

232 assay measures IL-6 and TNF-alpha proteins, gram-negative (GN) and gram-positive (GP) bacterial DNA,

233 Multidrug-resistant Gram-negative (GN) infections for which there are few av

234 e restricted the analysis to donors with MDR-Gram-negative (GN) organisms.

235 ures yielded no growth, no Staphylococcus or gram-negative growth was found for patients in group 2,

236 actam is an appropriate treatment option for gram-negative HABP/VABP, including in critically ill, hi

237 Vibrio cholerae is a Gram-negative human pathogen and the causative agent of

238 Cases were defined as 3GC-R-BSI or 3GC-R Gram-negative infection (3GC-R-GNI) (analysis 2), all ot

239 atment options for multidrug-resistant (MDR) gram-negative infection are growing.

240 allo-HCT subjects were studied (7.5% develop gram-negative infection), with 4,768 fecal samples for a

241 listin) for treatment of multidrug-resistant Gram-negative infections, many clinical laboratories are

242 oglycoside antibiotics are effective against Gram-negative infections, these drugs often cause irreve

243 s) play an important role in pathogenesis of Gram-negative infections.

244 beta-lactams, the major antibiotic class for gram-negative infections.

245 Gram-negative intestinal colonization is highly predicti

246 Gram-negative intestinal domination was associated with

247 omplex, which parallel recent studies in the Gram-negative intestinal pathogen Campylobacter jejuni.

248 C. burnetii is a Gram-negative intracellular bacterium that replicates wi

249 anism of resistance among colistin-resistant Gram-negative isolates and to detect PMCR for infection

250 Infection with the Gram-negative, microaerophilic bacterium Helicobacter py

251 diversity and ability to form biofilms, this Gram-negative nonfermenting bacterium can persist in the

252 efficacy against Gram-positive strains than Gram-negative ones.

253 control of Pseudomonas aeruginosa, a motile Gram-negative, opportunistic bacterial pathogen which fr

254 e or monoderm) and those with two membranes (Gram-negative or diderm) is a fundamental open question

255 oke fail to increase hepcidin in response to Gram-negative or Gram-positive infection.

256 re strongly associated with lower numbers of Gram-negative organisms at indoor sites (p < 0.0001).

257 athogens and mixed infections with yeast and Gram-negative organisms from the same positive blood cul

258 he methods of surface charge modulation that Gram-negative organisms may adopt for antibiotic resista

259 engineered to attach specifically to several Gram-negative organisms, including the human pathogens E

260 with infections due to carbapenem-resistant Gram-negative organisms.

261 The Gram-negative outer-membrane envelops the bacterium and

262 -DG) were assessed against Gram-positive and Gram-negative pathogenic and food spoilage bacteria, bot

263 system (T3SS), which is mainly expressed in Gram-negative pathogens and is essential for bacterial i

264 Gram-negative pathogens are enveloped by an outer membra

265 h activity against multidrug-resistant (MDR) Gram-negative pathogens as the pipeline of antibiotics i

266 high solubility and potent efficacy against Gram-negative pathogens in animal infection models.

267 otic classes have been approved for treating Gram-negative pathogens in decades.

268 Many gram-negative pathogens such as Neisseria meningitidis a

269 s, a Gram-positive bacterium, BCV rupture by Gram-negative pathogens such as Shigella flexneri or Sal

270 Many Gram-negative pathogens use a type III secretion system

271 ibacterial activity across Gram-positive and Gram-negative pathogens with N-linked 1,2,4-triazoles su

272 re, we detected LPS-derived lipid A from the Gram-negative pathogens, Escherichia coli (Ec, m/z 1797)

273 The focus is on Gram-negative pathogens, particularly bacteria on the WH

274 potent activity against multidrug-resistant gram-negative pathogens, such as carbapenem-resistant Ac

275 Given that ompA is highly conserved among Gram-negative pathogens, these studies not only provide

276 ent activity against ciprofloxacin-resistant Gram-negative pathogens.

277 nem activity against imipenem-nonsusceptible gram-negative pathogens.

278 antibacterial activity against high-priority Gram-negative pathogens.

279 ital for the success of clinically important Gram-negative pathogens.

280 vity, including against carbapenem-resistant gram-negative pathogens.

281 resistant (XDR) and pan-drug-resistant (PDR) Gram-negative pathogens.

282 pecies spanning different classes within the Gram-negative phylum Proteobacteria: Agrobacterium tumef

283 n aged 0.5-17 years with community acquired, gram-negative quinolone-resistant bacteriuria.

284 diatric institution with a low prevalence of Gram-negative resistance, the VG RDT facilitated antibio

285 ntimicrobial susceptibility testing (AST) in Gram-negative rod (GNR) bacteremia is compelling; howeve

286 us (43%), followed by streptococci (26%) and Gram negative rods (18%).

287 eonatal mice to more severe infection during Gram-negative sepsis.

288 In 3 gram-negative septic transfusion cases, we performed met

289 The Gram-negative Shigella species are close relatives of Es

290 In the Gram-negative social bacterium, Myxococcus xanthus, a pu

291 ins are covalently attached to PG in several Gram-negative species, including Coxiella burnetii, Agro

292 .7%) were vancomycin-sensitive; among the 12 gram-negative strains tested, all 12 (100%) were ceftazi

293 of available genome sequences of over 1,300 Gram-negative strains.

294 The genome of the Gram-negative symbiont Bacteroides thetaiotaomicron, a d

295 sistance genes, and both Pan Candida and Pan Gram-Negative targets that are unique to the BCID-GP Pan

296 greement and NPA for the Pan Candida and Pan Gram-Negative targets were 92.4% and 95.7% for the forme

297 MDR gram-negative therapeutic trials are often inefficient,

298 Proteus mirabilis is a Gram-negative uropathogen and frequent cause of catheter

299 As 80% of prostatitis cases are caused by Gram-negative uropathogenic Escherichia coli (UPEC) or G

300 1500 ppm) as well as sensitive and resistant Gram negative (using 125 ppm) bacteria.